Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
G1 Therapeutics
Biotech
Pepper spices up pipeline with $135M deal for G1's cancer drug
With $6.5 million in seed funding, Pepper Bio has decided to shake up its portfolio by acquiring a CDK4/6 inhibitor from G1 Therapeutics.
James Waldron
May 1, 2024 10:32am
EQRx abandons low cost drug plan, cuts programs and staff
May 8, 2023 7:19pm
G1 sheds staff while Sorrento WARNs of layoffs
Mar 1, 2023 2:02pm
GSK's ex-vaccine, pharma lead jumps ship to run G1
Oct 2, 2020 8:30am
G1 Therapeutics' chemo companion nabs speedy FDA review
Aug 17, 2020 10:40am
EQRx bags rights to EGFR inhibitor to drive discount me-too plan
Jul 23, 2020 9:00am
